124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMA Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Heo, J
  • Reid, T
  • Lim, HY
  • Ruo, Leyo
  • Kim, CW
  • Bloomston, M
  • Chung, HC
  • Rhee, BG
  • Patt, R
  • Breitbach, CJ
  • Hickman, T
  • Bell, JC
  • Hwang, TH
  • Kirn, DH

publication date

  • April 2010